Article

High-speed, high-resolution imaging of eye in sight

Fort Lauderdale, FL-Ultra-high-speed, ultra-high-resolution spectral-domain optical coherence tomography (SD-OCT) seems to have surpassed the slow-speed, low-resolution OCT and provides video images of the minute structural changes in the glaucomatous eye.

Teresa Chen, MD, demonstrated the capabilities of the instrument at the annual meeting of the Association for Research in Vision and Ophthalmology. Johannes F. de Boer, PhD, of Massachusetts General Hospital/Wellman Center for Photomedicine, Harvard Medical School, Boston, developed the SD-OCT.

How SD-OCT works

The previous-generation time-domain OCT differs from SD-OCT in that it has lower resolution (about 10 μm) and slower acquisition speed. Ultra-high-resolution time-domain OCT solved the problem of resolution but is extremely expensive. The titanium-sapphire laser source alone that is commonly used for ultra-high-resolution time-domain OCT can cost about $80,000, according to Dr. Chen. This is compared with about $8,000 for the superluminescent diode laser source.

The primary difference between SD-OCT and the previous OCT instruments is in the way information is processed, she explained. When the light returns from the eye and the reference mirror, it is processed by a spectrometer, hence the term SD-OCT. The data are then processed by Fourier transformation, and the data can then be used to create an image.

"For the first time we have a system that has simultaneous ultra-high resolution and ultra-high acquisition speed," Dr. Chen said. "It is more affordable and easy to maintain compared with ultra-high-resolution time-domain OCT."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
© 2025 MJH Life Sciences

All rights reserved.